In vitro nanodelivery of silibinin as an anticancer drug under pH response

Journal of Drug Delivery Science and Technology

Volumn 24, Issue 6, 2014, Pages 579-584

  Tan, J M ^a   Karthivashan, G ^a   Arulselvan, P ^a   Fakurazi, S ^a   Hussein, M Z ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Carboxvlic acid; Cytotoxicity assay; Nanomedicine; Ph responsive; Single walled carbon nanotubes; Sustained release

Indexed keywords

SILIBININ; SINGLE WALLED NANOTUBE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; DRUG CONJUGATION; DRUG SOLUBILITY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

EID: 84921723092     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(14)50122-0     Document Type: Article

References (35)

1. Li HL, Zhao X B., Ma Y.K., Zhai G.X, Li L.B, Lou H X - Enhancements of gastrointestinal absorption of quercetm by solid lipid nanoparticles. - J Control. Release, 133, 238-244, 2009.
2. Yu J., Zhu Y., Wang L, Peng M., Tong S., Cao X., Qiu H., Xu X M - Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phosphohpid-mixed micelles. - Acta Pharmacol. Sin., 31, 759-764, 2010
3. Elmowafy M., Viitala T, Ibrahim H.M., Abu-Elyazid S.A., Samy A., Kassem A., Yliperttula M - Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake. - Eur. J. Pharm Sci, 50, 161-171, 2013.
4. Jakki R, Afzal Syed M., Kandadi P., Veerabrahma K. - Development of a self - microemulsifying drug delivery system of domperidone: in vitro and in vivo characterization - Acta Pharm., 63, 241-251, 2013.
5. Cao X., Deng W, Fu M., Zhu Y, Liu H, Wang L., Zeng J., Wei Y, Xu X., Yu J. - Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles in vitro release kinetics and in vitro/in vivo correlations in beagle dogs. - Eur. J. Pharm Sci., 48, 64-71, 2013
6. Zhang L., Wang S, Zhang M., Sun J - Nanocarners for oral drug delivery - J. Drug Target., 21, 515-527, 2013
7. lijima S. - Helical microtubules of graphitic carbon. - Nature, 354, 56-58, 1991
8. Iijima S - Carbon nanotubes: past, present, and future. - Phys. B Condens Matter., 323, 1-5, 2002.
9. Smart S.K., Cassady A.I., Lu G.Q, Martin D J. - The biocompat - ibility of carbon nanotubes. - Carbon, 44, 1034-1047, 2006.
10. Liu Z, Tabakman S, Welsher K., Dai H - Carbon nanotubes in biology and medicine, in vitro and in vivo detection, imaging and drug delivery - Nano Res, 2, 85-120, 2009.
11. Bianco A., Kostarelos K, Prato M - Applications of carbon nanotubes in drug delivery - Curr Opin. in Chem. Biol., 9, 674-679, 2005.
12. Liu J., Rinzler AG, Dai H., Hafner J H., Bradley R.K., Boul P J, Lu A., Iverson T., Shelimov K. Huffman C.B., Rodriguez-Macias F, Shon Y.S., Lee T.R., Colbert D.T., Smalley R E. - Fullerene pipes - Science, 280, 1253-1256, 1998
13. Lu F., Gu L, Meziani M.J., Wang X., Luo P.G., Veca L M., Cao L, Sun Y P. - Advances in bioapplications of carbon nanotubes. - Adv. Mater., 21, 139-152, 2009.
14. Klumpp C, Kostarelos K., Prato M., Bianco A. - Functionahzed carbon nanotubes as emerging nanovectors for the delivery of therapeutics - Biochimica et Biophysica Acta, 1758, 404-412, 2006.
15. Ji Z., Lin G, Lu Q., Meng L., Shen X, Dong L, Fu C., Zhang X. - Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system - J Colloid Interface Sci, 365, 143-149, 2012.
16. Hoh CS., Boocock D J., Marczylo TH, Brown V.A., Cai H., Steward W.P, Berry D.P., Gescher A. J. - Quantitation of silibinin, aputative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites. - J. Agric. Food Chem., 55, 2532-2535, 2007.
17. Verschoyle R.D., Greaves P., Patel K, Marsden D.A., Brown K., Steward W P, Gescher A.J. - Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: Relationship with silibinin levels. - Eur. J. Cancer, 44, 898-906, 2008
18. Hruby K., Csomos G., Fuhrmann M., Thaler H - Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. - Hum. Toxicol., 2, 183-195, 1983.
19. Pares A., Planas R., Torres M., Caballena J., Viver J M, Acero D., Panes J., Rigau J., Santos J., Rodes J - Effects of Silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. - J. Hepatol., 28, 615-621, 1998.
20. Magliulo E, Gagliardi B., Fion G P. - Results of a double blind study on the effect of Silymarin in the treatment of acute viral hepatitis, carried out at two medical centres. - Med. Klin., 73, 1060-1065, 1978
21. Sonnenbichler J., Scalera F, Sonnenbichler I., Weyhenmeyer R. - Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. - J. Pharmacol. Exp. Ther, 290, 1375-1383, 1999.
22. Yang L.X., Huang K.X., Li H.B., Gong J.X., Wang F., Feng YB., Tao Q F, Wu Y.H, Li X K., Wu X M, Zeng S., Spencer S., Zhao Y, Qu J. - Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives. - J. Med. Chem., 52, 7732-7752, 2009.
23. Singh R R., Agarwal R - Prostate cancer prevention by silibinin - Curr. Cancer Drug Targets, 4, 1-11, 2004.
24. Karim B O., Rhee K J, Liu G., Zheng D., Huso D.L - Chemo-prevention utility of silibinin and Cdk4 pathway inhibition in Apc-/+ mice. - BMC Cancer, 13, 157, 2013.
25. Tan J.M., Karthivashan G., Arulselvan P, Fakurazi S., Hussein M.Z. - Characterization and in vitro sustained release of silibinin from pH responsive carbon nanotube-based drug delivery system. - J Nanomater., Article ID 439873, 10 pages, 2014.
26. Arepalli S, Nikolaev P., Gorelik O, Hadjiev V.G., Holmes W., Files B., Yowell L. - Protocol for the characterization of single - wall carbon nanotube material quality. - Carbon, 42, 1783-1791, 2004
27. Beim T., Epron F. - Characterization methods of carbon nano - tubes: a review - Mater Sci Eng B, 119, 105-118, 2005
28. Hadidi N, Kobarfard F., Nafissi-Varcheh N., Aboofazeli R. - Optimization of single-walled carbon nanotube solubility by noncovalent PEGylation using experimental design methods. - Int. J Nanomedicine, 6, 737-746, 2011.
29. Kim UJ, Furtado CA., Liu X., Chen G., Eklund P.C. - Raman and IR spectroscopy of chemically processed single-walled carbon nanotubes. - J. Am. Chem. Soc, 127, 15437-15445, 2005.
30. Adeli M., Hakimpoor F, Ashiri M., Kabiri R., Bavadi M. - Anticancer drug delivery systems based on noncovalent interactions between carbon nanotubes and linear-dendritic copolymers. - Soft Matter., 7, 4062-4070, 2011.
31. Shieh YT, Liu G L, Wu H.H., Lee C.C. - Effects of polarity and pH on the solubility of acid-treated carbon nanotubes in different media. - Carbon, 45, 1880-1890, 2007.
32. Dorniani D, Hussein M Z., Kura A.U., Fakurazi S., Shaan A.H., Ahmad Z - Preparation of Fe304 magnetic nanoparticles coated with gallic acid for drug delivery. - Int. J. Nanomedicine, 7, 5745-5756, 2012.
33. Ho Y.S., Ofomaja A E. - Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. - J. Hazard Mater, 129, 137-142, 2006.
34. Hussein Al Ali S H., Al-Qubaisi M, Hussein M Z., Ismail M, Zainal Z, Hakim M N. - Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumme nanocom-posites for inhibition of angiotensin-converting enzyme. - Int. J. Nanomedicine, 7, 4251-4262, 2012.
35. Kura AU., Hussein Al Ali S H., Hussein M.Z., Fakurazi S., Arulselvan P. - Development of acontrolled-release antiparkinsonian nanodelivery system using levodopa as the active agent. - Int. J. Nanomedicine, 8, 1103-1110, 2013